| Wearable sensors for clinical applications in epilepsy, Parkinson's disease, and stroke: a mixed-methods systematic review |
33 |
| Neurological update: MOG antibodydisease |
29 |
| An update on genetic frontotemporal dementia |
27 |
| Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients |
23 |
| Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials |
21 |
| Spinocerebellar ataxia: an update |
21 |
| Vitamin D for the treatment of multiple sclerosis: a meta-analysis |
21 |
| Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial |
20 |
| Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome |
20 |
| Incidence of Parkinson's disease in a large patient cohort with idiopathic smell and taste loss |
20 |
| Transthyretin familial amyloid polyneuropathy: an update |
19 |
| Advances in understanding nociception and neuropathic pain |
19 |
| Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells |
18 |
| Current treatment of central retinal artery occlusion: a national survey |
18 |
| NFL is a marker of treatment response in children with SMA treated with nusinersen |
18 |
| Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review |
17 |
| Primary progressive aphasia: a clinical approach |
17 |
| Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation |
15 |
| The clinical and radiological profile of primary lateral sclerosis: a population-based study |
14 |
| MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein |
13 |
| Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment |
13 |
| Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS) |
13 |
| Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy |
13 |
| The Dizziness Handicap Inventory does not correlate with vestibular function tests: a prospective study |
13 |
| Myasthenia gravis and infectious disease |
13 |
| Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations |
13 |
| Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study |
12 |
| Advances in immunotherapeutic research for glioma therapy |
12 |
| Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study |
12 |
| Alcohol-related peripheral neuropathy: a systematic review and meta-analysis |
12 |
| A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study |
12 |
| Structural cerebellar correlates of cognitive functions in spinocerebellar ataxia type 2 |
12 |
| Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders |
12 |
| The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study |
12 |
| Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests |
12 |
| Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders |
12 |
| High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria |
12 |
| Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort |
11 |
| Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study |
11 |
| Prognostic factors in ALS: a comparison between Germany and China |
11 |
| Update on opsoclonus-myoclonus syndrome in adults |
11 |
| Update on human African trypanosomiasis (sleeping sickness) |
11 |
| The clinical features and outcome of scan-negative and scan-positive cases in suspected cauda equina syndrome: a retrospective study of 276 patients |
11 |
| Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study |
11 |
| Quality of life in idiopathic dystonia: a systematic review |
11 |
| Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease |
11 |
| Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia |
11 |
| Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course |
10 |
| Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China |
10 |
| Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany |
10 |
